ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Hematology and Hematological Malignancies
Volume 13 - 2025 | doi: 10.3389/fped.2025.1557212
This article is part of the Research TopicAnemia in Children: From Nutritional Deficits to Genetic DisordersView all 3 articles
Differentiating Primary Bone Marrow Failure Syndromes in Children: A Retrospective Analysis of Early Clinical and Laboratory Features
Provisionally accepted- Department of Pediatrics, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To investigate the early clinical characteristics of different subtypes of primary bone marrow failure syndrome (BMFS) in children and identify predictive factors for early diagnosis, thereby improving the ability to differentiate BMFS at an early stage. Methods: A retrospective analysis was conducted on the clinical and laboratory data of children with primary BMFS who received regular follow-up visits exceeding one year at the First Affiliated Hospital of Shandong First Medical University from January 2020 to September 2024. Based on long-term follow-up results, the children were reclassified into subgroups, and early clinical features, blood counts, and bone marrow examination results were compared across groups. Univariate and multivariate analyses were performed.Results: A total of 167 pediatric patients with primary BMFS were included in this study, of whom 112 (67.1%) were diagnosed with aplastic anemia (AA), 34 (20.3%) with refractory cytopenia (RCC), and 21 (12.6%) with idiopathic cytopenia of undetermined significance (ICUS). Significant statistical differences were observed among the three groups in terms of gender, red blood cell and platelet transfusion volumes within the first three months of disease onset, infection incidence, initial platelet and neutrophil counts, the lowest platelet and neutrophil values during the early stage of the disease, initial reticulocyte (RET) count and percentage, mean corpuscular volume (MCV),mean corpuscular hemoglobin(MCH),mean corpuscular hemoglobin concentration (MCHC),red cell distribution width (RDW),bone marrow cellularity, number of megakaryocytes, enzyme-linked tissue staining for megakaryocytes, and dysplasia in bone marrow smears (p<0.05). Among these, gender, initial RET count, and bone marrow cellularity were identified as independent predictors for AA (p<0.01). Conclusion: Early manifestations of pediatric BMFS are characterized by pancytopenia and bone marrow hematopoietic failure; however, different subtypes exhibit variations in early clinical features and laboratory findings. Early identification of these characteristics may improve diagnostic accuracy and facilitate more effective clinical management.
Keywords: bone marrow failure syndrome, aplastic anemia, Refractory cytopenia in children, Idiopathic cytopenia of undetermined significance, Early clinical characteristics
Received: 08 Jan 2025; Accepted: 24 Apr 2025.
Copyright: © 2025 Leng, Zhao, Li, Gu, Han, Ding, Zhang, Li, Feng, Lin, Zhao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hong Mei Wang, Department of Pediatrics, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.